Home › Funds › Vestal Point Capital, LP › BBNX
Vestal Point Capital, LP position in BBNX
BETA BIONICS INC · Health Care
Vestal Point Capital, LP reported holding 1,600,000 shares of BBNX (BETA BIONICS INC) in its Q2 2026 13F filing — a position valued at US$25.1M, representing 0.59% of its reported portfolio and ranking #40 among its reported holdings. Vestal Point Capital, LP has disclosed BBNX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Vestal Point Capital, LP's BBNX position evolved
Vestal Point Capital, LP first disclosed a stake in BBNX in Q2 2025 at 550,000 shares (US$8.0M). The position peaked in Q2 2026 at 1,600,000 shares, worth US$25.1M. Across 5 filings, Vestal Point Capital, LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,600,000 shares valued at US$25.1M — a reduction of -611,518 shares quarter over quarter.. Notable position changes include a 269% increase in Q1 2026 (shares rose 56% over the following quarter), a 28% trim in Q2 2026 (shares rose 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 550.00K | $8.01M | New |
| Q3 2025 | 600.00K | $11.92M | Add |
| Q4 2025 | 600.00K | $18.28M | Hold |
| Q1 2026 | 2.21M | $22.16M | Add |
| Q2 2026 | 1.60M | $25.07M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BBNX and 13F data
BBNX (BETA BIONICS INC) is a Health Care company. 52 other funds we track also report a position in BBNX — the largest reported positions include EVENTIDE ASSET MANAGEMENT, LLC (US$98.1M), Soleus Capital Management, L.P. (US$68.8M), Sands Capital Alternatives, LLC (US$58.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BBNX
- EVENTIDE ASSET MANAGEMENT, LLC 6.25M sh · $98.05M · Q2 2026
- Soleus Capital Management, L.P. 4.39M sh · $68.85M · Q2 2026
- Sands Capital Alternatives, LLC 3.71M sh · $58.11M · Q2 2026
- Omega Fund Management, LLC 1.32M sh · $20.62M · Q2 2026
- Eversept Partners, LP 1.25M sh · $19.58M · Q2 2026
- Divisadero Street Capital Management, LP 1.11M sh · $17.45M · Q2 2026
- Bruce & Co., Inc. 665.70K sh · $10.43M · Q2 2026
- Tri Locum Partners LP 493.34K sh · $7.73M · Q2 2026
- PURA VIDA INVESTMENTS, LLC 281.16K sh · $4.41M · Q2 2026
More on Vestal Point Capital, LP
FAQ
How long has Vestal Point Capital, LP held BBNX?
Vestal Point Capital, LP has disclosed BBNX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is Vestal Point Capital, LP's current position in BBNX?
As of Q2 2026, Vestal Point Capital, LP holds 1.60M shares of BBNX (BETA BIONICS INC), valued at $25.07M, representing 0.59% of its reported portfolio and ranking #40.
Has Vestal Point Capital, LP been buying or selling BBNX?
In the latest 13F filing (Q2 2026), Vestal Point Capital, LP reduced its position in BBNX. The position peaked in Q2 2026 at 1.60M shares.
Which other funds hold BBNX?
Other major institutional holders of BBNX include EVENTIDE ASSET MANAGEMENT, LLC, Soleus Capital Management, L.P., Sands Capital Alternatives, LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.